Max Healthcare Institute Crecimiento futuro
Future controles de criterios 3/6
Max Healthcare Institute se prevé un crecimiento anual de los beneficios y los ingresos de 20.8% y 21.8% respectivamente. Se prevé que el BPA sea de grow en 20.3% al año. Se prevé que la rentabilidad de los fondos propios sea de 15.8% en 3 años.
Información clave
18.9%
Tasa de crecimiento de los beneficios
18.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 26.6% |
| Tasa de crecimiento de los ingresos | 19.0% |
| Rentabilidad financiera futura | 16.1% |
| Cobertura de analistas | Good |
| Última actualización | 08 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Is Max Healthcare Institute (NSE:MAXHEALTH) Using Too Much Debt?
Jul 24Max Healthcare Institute Limited (NSE:MAXHEALTH) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Jun 01Have Insiders Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares This Year?
Feb 21What Percentage Of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares Do Insiders Own?
Jan 16
We Think Max Healthcare Institute (NSE:MAXHEALTH) Is Taking Some Risk With Its Debt
Dec 20Who Has Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Nov 15What Type Of Shareholders Own The Most Number of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Oct 02Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2027 | 115,497 | 22,128 | 12,410 | N/A | 2 |
| 3/31/2026 | 104,123 | 20,185 | 14,248 | N/A | 14 |
| 3/31/2025 | 83,561 | 16,017 | 6,625 | N/A | 15 |
| 3/31/2024 | 68,622 | 13,271 | 2,443 | N/A | 15 |
| 12/31/2023 | 51,976 | 10,570 | N/A | N/A | N/A |
| 9/30/2023 | 50,044 | 9,901 | 7,141 | 11,564 | N/A |
| 6/30/2023 | 47,807 | 11,708 | N/A | N/A | N/A |
| 3/31/2023 | 45,626 | 11,035 | 8,736 | 12,092 | N/A |
| 12/31/2022 | 42,799 | 9,763 | N/A | N/A | N/A |
| 9/30/2022 | 41,143 | 9,437 | 3,873 | 9,507 | N/A |
| 6/30/2022 | 39,976 | 6,310 | N/A | N/A | N/A |
| 3/31/2022 | 39,366 | 6,051 | 1,872 | 7,405 | N/A |
| 12/31/2021 | 37,978 | 5,510 | N/A | N/A | N/A |
| 9/30/2021 | 36,193 | 4,516 | 1,486 | 3,086 | N/A |
| 6/30/2021 | 32,486 | 3,236 | N/A | N/A | N/A |
| 3/31/2021 | 25,080 | -1,375 | -6 | 1,179 | N/A |
| 12/31/2020 | 27,772 | -1,177 | N/A | N/A | N/A |
| 9/30/2020 | 22,487 | -2,134 | 3,024 | 3,911 | N/A |
| 6/30/2020 | 14,849 | -2,681 | N/A | N/A | N/A |
| 3/31/2020 | 10,590 | 590 | -130 | 771 | N/A |
| 12/31/2019 | 10,081 | 268 | N/A | N/A | N/A |
| 9/30/2019 | 18,609 | 720 | N/A | N/A | N/A |
| 6/30/2019 | 17,719 | 360 | N/A | N/A | N/A |
| 3/31/2019 | 16,939 | -30 | -268 | 890 | N/A |
| 6/30/2018 | 17,053 | -704 | N/A | N/A | N/A |
| 3/31/2018 | 17,303 | -302 | 167 | 822 | N/A |
| 3/31/2017 | 16,085 | -14 | N/A | 1,561 | N/A |
| 3/31/2016 | 14,343 | -180 | N/A | 7,225 | N/A |
| 3/31/2015 | 7,896 | -381 | N/A | 387 | N/A |
| 3/31/2014 | 9,445 | -646 | N/A | 732 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. tasa de ahorro: MAXHEALTH(20.7% al año) es superior a la tasa de ahorro (6.7%).
Beneficios frente mercado: MAXHEALTHSe prevé que los beneficios de la empresa (20.7% al año) crezcan más deprisa que el mercado Indian (16.4% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de MAXHEALTH crezcan, pero no significativamente.
Ingresos vs. Mercado: MAXHEALTHSe prevé que los ingresos de la empresa (21% al año) crezcan más deprisa que los del mercado Indian (9.2% al año).
Ingresos de alto crecimiento: MAXHEALTHSe prevé que los ingresos de la empresa (19% al año) crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
Futura rentabilidad financiera (ROE): MAXHEALTHSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (15.8%).